EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity

Senta M Kapnick iD, Emily A Gosselin iD, Shannon J Tsai, Robert S Oakes iD, Zahra A Habibabady, Marian A Ackun-Farmmer, Sean T Carey, Shrey A Shah iD, Ruochen Shen iD, Eugene Froimchuk, Haleigh B Eppler, Christopher J Bridgeman und 10 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2409563122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Senta M Kapnick und 21 weiteren Autor:innen. Beteiligte Einrichtung: Robert E. Fischell Institute for Biomedical Devices, University of Maryland, College Park, MD 20742. Hauptthemen laut MEDLINE: Lymph Nodes, Autoimmunity, Myelin Sheath, Multiple Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Insitutes of Health, NHLBI NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of tolerogenic, antigen-specific immunotherapies could overcome limitations of existing treatments for inflammatory autoimmune diseases by achieving potent, durable remission without impacting healthy immune surveillance. Here, we deliver diffusion-limited polymer depots to lymph nodes to locally guide T cell fates for the treatment of multiple sclerosis (MS), an autoimmune disease that occurs when the immune system mistakenly attacks myelin. In preclinical MS models, depots loaded with myelin self-antigen and tolerizing cues mediate localized retention of activated CD4 T cells, promote myelin-specific regulatory T cells, and reshape inflammation in the central nervous system (CNS) to eliminate lesions. Selective disease reversal is achieved with a single treatment that induces long-lasting remission without hindering healthy responses to vaccine challenge with foreign antigen. Furthermore, depots offer favorable chemistry and manufacturing control features and are well tolerated in non-human primates. This work supports a clinically feasible concept for inducing safe, effective, antigen-specific tolerance without systemic or repeated dosing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymph NodesAutoimmunityMyelin SheathMultiple SclerosisEncephalomyelitis, Autoimmune, ExperimentalAnimalsMiceImmunotherapyT-Lymphocytes, RegulatoryFemaleAutoantigensImmune ToleranceHumansCD4-Positive T-LymphocytesMice, Inbred C57BL

Stichwörter der Autor:innen

biomaterialsimmune engineeringimmunotherapynanotechnologytolerance

Substanzen

Autoantigens

Autor:innen und Institutionen

  • Robert E. Fischell Institute for Biomedical Devices, University of Maryland, College Park, MD 20742.
  • Department of Veterans Affairs, Veterans Affairs Maryland Health Care System, Baltimore, MD 21201.
  • Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742.
  • Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02114.
  • Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201.
  • Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201.

ORCID-Profile: Senta M Kapnick, Emily A Gosselin, Robert S Oakes, Shrey A Shah, Ruochen Shen, Ryan A McIlvaine, Sheneil K Black, Christopher M Jewell

Förderung

  • National Insitutes of Health
  • NHLBI NIH HHS
  • BLRD VA
  • U.S. Department of Veterans Affairs (VA)
  • NIAID NIH HHS
  • NIDA NIH HHS
  • Juvenile Diabetes Research Foundation
  • University of Maryland Research and Innovation Seed Grant Program

Zitieren

APA

Kapnick, S. M., Gosselin, E. A., Tsai, S. J., Oakes, R. S., Habibabady, Z. A., Ackun-Farmmer, M. A., Carey, S. T., Shah, S. A., Shen, R., Froimchuk, E., Eppler, H. B., Bridgeman, C. J., Yanes, A. A., McIlvaine, R. A., Noshin, M., Tostanoski, L. H., Black, S. K., Zeng, X., Azimzadeh, A., …, & Jewell, C. M. (2025). Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2409563122

Vancouver

Kapnick SM, Gosselin EA, Tsai SJ, Oakes RS, Habibabady ZA, Ackun-Farmmer MA, et al. Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2409563122

BibTeX
@article{Kapnick2025,
  author = {Kapnick, Senta M and Gosselin, Emily A and Tsai, Shannon J and Oakes, Robert S and Habibabady, Zahra A and Ackun-Farmmer, Marian A and Carey, Sean T and Shah, Shrey A and Shen, Ruochen and Froimchuk, Eugene and Eppler, Haleigh B and Bridgeman, Christopher J and Yanes, Alexis A and McIlvaine, Ryan A and Noshin, Maeesha and Tostanoski, Lisa H and Black, Sheneil K and Zeng, Xiangbin and Azimzadeh, Agnes and Pierson, Richard N and Bromberg, Jonathan S and Jewell, Christopher M},
  title = {Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2409563122}
}
Kostenlos starten →